NCT01594905View on ClinicalTrials.gov

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

PHASE4UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir + Tenofovir (MDR group)

Entecavir 1.0mg + Tenofovir 300mg

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

lead

Yonsei University

OTHER

NCT01594905 - Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection | Biotech Hunter | Biotech Hunter